Luxshare Precision: A Further Step from Tier 2 to Tier 1 Automotive Supplier
Hong Kong, Sept 21, 2023 – (ACN Newswire) – Luxshare Precision released its 2023 interim…
Year: 2023
Starbucks Announces Increase in Quarterly Cash Dividend
Commemorates Thirteenth Consecutive Annual Increase with CAGR of Approximately 20% SEATTLE–(BUSINESS WIRE)–Starbucks Corporation (NASDAQ: SBUX)…
BrainChip Engages VVDN to Deliver Industry’s First Commercial Edge Box Based on Neuromorphic Technology
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first…
Emergent Cold LatAm Expands Brazil Network with São Paulo Acquisition
Newly constructed building offers modern storage capacity, a huge capacity for new customers, and service…
Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera
WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera
WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
Full commercial launch of NexoBrid marks important first step to becoming the new standard of…
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
Full commercial launch of NexoBrid marks important first step to becoming the new standard of…
Spectral AI to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
DALLAS, Sept. 20, 2023 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI”…
Spectral AI to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
DALLAS, Sept. 20, 2023 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI”…
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023…
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023…
Societal CDMO Announces Corporate Restructuring
Strategic Realignment Designed to Right Size Organization to Address Macro Pharma Market Financing Challenges and…
Societal CDMO Announces Corporate Restructuring
Strategic Realignment Designed to Right Size Organization to Address Macro Pharma Market Financing Challenges and…
Dyne Therapeutics Receives FDA Orphan Drug Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1
– On Track to Report Initial Data from the Global, Multiple Ascending Dose Phase 1/2…
PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
PRINCETON, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech…